Research and Markets: Pfizer Inc - Detailed Product Pipeline - Management Information, Deals and Alliances and Recent News

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/2fa417/pfizer_incdetaile) has announced the addition of the "Pfizer Inc-Detailed Product Pipeline" company profile to their offering.

Pfizer Inc-Detailed Product Pipeline contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

Scope of the reports

Pipeline Report provides the user with real detail on a company's pipeline.

In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company's product pipeline and disease hub classification.

Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company's deals and alliances and recent corporate news including key milestones.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.

Key Topics Covered:

Business Summary

Headquarters

Financials

Product Glance

  • Products by Phase of Development
  • Products by Disease Hub Classification
  • Products by Indication

Patent Expirations

Upcoming Milestones

Company Sales Figures

  • Product Revenue

All Values in US Dollar (in millions)

  • Revenue by Product Line

All Values in US Dollars (in millions)

Product Pipeline

Product Details

Recent Updates

  • Company Announcements
  • Deals & Alliances
  • Intellectual Property
  • Mergers & Acquisitions
  • Product Updates
  • Regulatory

For more information visit http://www.researchandmarkets.com/research/2fa417/pfizer_incdetaile

Source: Life Science Analytics



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   United States  North America

INDUSTRY KEYWORDS:   Health  Pharmaceutical

MEDIA:

Logo
 Logo

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.